![]() PepGen PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases. | |||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2018 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations HQ | Locations Cambridge, GB HQ | Locations Boston, US HQ |
Employees | Employees N/A | Employees 3014% decrease | Employees 8127% increase |
Financial | |||
Net income | Net income (kr10.7m) (FY, 2024) | Net income N/A | Net income ($89.7m) (FY, 2025) |

Mogrify is a biotech company advancing cell therapies.
View company
PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases.
View company